NP+PA Perspectives in Dermatology | JCAD | The Journal of Clinical and Aesthetic Dermatology

Full Digital Editions:

NP+PA Perspectives in Dermatology: March–April 2024

NP+PA Perspectives in Dermatology: January-February 2024

NP+PA Perspectives in Dermatology: December 2023

Current Issue: Featured Articles

Dermatological Conditions in Skin of Color— Debunking Vitiligo Myths

J Clin Aesthet Dermatol. 2022;15(9 Suppl 1):S10–11 by Archana M. Sangha, MMS, PA-C Ms. Sangha is a medical science liaison for Incyte in Wilmington, Delaware. Prior to that, she spent over a decade as...

Editorial Message from Guest Editor Susan Mayne, DNP, FNP-C, DCNP

Dear Colleagues: The pharmaceutical floodgates have recently burst, and many of us struggle to keep up with the safety and efficacy of new medications along with emerging safety risks of familiar medications....

Spotlight Interview: Susan Mayne, DNP, FNP-C, DCNP

J Clin Aesthetic Dermatol 2022;15(6 Suppl 1):S11–S12 Susan Mayne, DNP, FNP-C, DCNP, is a Family Nurse Practitioner who practices dermatology at University Hospitals Cleveland Medical Centers (UHCMC) in...

Dermatological Conditions in Skin of Color — A Look at Skin Cancer in Skin of Color

J Clin Aesthet Dermatol. 2022;15(6 Suppl 1):S17–S18 by Archana M. Sangha, MMS, PA-C Ms. Sangha is a medical science liaison for Incyte in Wilmington, Delaware. Prior to that, she spent over a decade as...

Interleukin-17 Inhibitor Combination Therapies for the Treatment of Psoriasis: A Systematic Review

J Clin Aesthet Dermatol. 2022;15(6 Suppl 1):S19–S25,31 by Amylee Martin, BS; Akshitha Thatiparthi, BS; Jeffrey Liu, BS; and Jashin J. Wu, MD FUNDING: No funding was provided for the preparation of this...

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next

Trending on JCAD TV

TJ Chao, PA-C: Utilizing Topical Treatments for Patients with Atopic Dermatitis

Atopic Dermatitis Advisor Audio Series:

Incorporating Topical and Oral Treatments into Practice

Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic dermatitis has shown to provide a rapid decrease in symptoms, particularly pruritus.